Company Information

Company Novo Nordisk AS
www.novonordisk.com
Type:
Company
Country:
Denmark
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
18 March 2002
Next Communication on Progress (COP) due on:
31 December 2023

Financial Information


Non-Financial Information

Affiliated Subsidiaries

Country Company Name
Denmark NNE A/S
Ukraine Novo Nordisk Ukraine, LLC

Communication On Progress

Published On Title Level/Status
2022-04-07 Communication on Progress Advanced
2021-04-09 Communication on Progress Advanced
2020-02-07 Communication on Progress 2019 Advanced
2019-02-07 Communication on Progress Advanced
2018-02-08 Communication on Progress 2017 Advanced
2017-03-24 Communication on Progress 2016 Advanced
2016-04-15 Communication on Progress 2015 Advanced
2015-11-25 Grace Letter Not applicable
2015-02-04 Novo Nordisk Communication on Progress 2014 Advanced
2014-02-05 Novo Nordisk Communication on Progress 2013 Advanced
2013-02-05 Novo Nordisk Communication on Progress 2012 Advanced
2012-02-10 Novo Nordisk Communication on Progress 2011 Advanced
2011-02-24 2010 Communication on Progress Advanced
2010-02-24 2010 Communication on Progress Not applicable
2009-03-03 Novo Nordisk's Communication on Progress 2008 Not applicable
2008-03-30 Novo Nordisk Annual Report 2007 Not applicable
2007-04-10 Novo Nordisk Annual Report 2006 Not applicable
2006-04-05 Novo Nordisk's Communication on Progress 2005 Not applicable
2005-09-09 Global Compact index Not applicable
2004-06-21 Sustainability Report 2003 Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.